ADORA2A and early-onset autosomal dominant Alzheimer disease: In support to our findings, A2AR blockade using SCH58261 was proven to be effective in maintaining synaptic integrity and preventing synaptotoxicity caused by different insults such as Alzheimer’s disease [75, 76], chronic stress [41, 77], and convulsion [78].